ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2012

Abstract Number: 2392

Blood Vessel Instability and Oxidative Damage in Giant Cell Arteritis

Danielle Molloy1, Jennifer McCormick2, Mary Connolly2, Muhammad Haroon3, Douglas J. Veale2, Conor Murphy4, Ursula Fearon2 and Eamonn S. Molloy1, 1Rheumatology, St. Vincent's University Hospital, Dublin 4, Ireland, 2Rheumatology, Dublin Academic Medical Center, St. Vincent's University Hospital, Dublin, Ireland, 3Department of Rheumatology, Dublin Academic Medical Centre, St. Vincent's University Hospital, Dublin, Ireland, 4Department of Ophthalmology, Royal Victoria Eye and Ear Hospital, Dublin, Ireland

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2012

Keywords: Angiogenesis, cytokines, giant cell arteritis and vasculitis

Session Information

Title: Vasculitis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Giant cell arteritis (GCA) is the most common form of primary vasculitis. The pathogenesis is incompletely understood, but involves neoangiogenesis and inflammatory infiltration of the arterial wall. The aim of the present study was to assess blood vessel stability and oxidative damage in patients with the condition and correlate with disease activity.

Methods:

20 patients with a clinical diagnosis of GCA were included, 16 of whom had a positive temporal artery biopsy. Temporal artery (TA) sections were assessed for blood vessel maturity (%BVM) by dual-immunofluorescent staining for Factor VIII/αSMA.  Oxidative DNA damage (8-oxo-7,8-dihydro-2’-deoxyguanosine; 8-oxo-dG), lipid peroxidation (4-hydroxy-2-nonenal; 4-HNE),  angiogenic growth factor Angiopoietin 2 (Ang2) and it receptor Tie-2 were assessed by immunohistochemistry. Ex vivo TA explant cultures were established directly from fresh biopsy specimens (n=4) and spontaneous release of pro-angiogenic factors were examined by ELISA and gelatine zymography. Patients were categorised into low disease (CRP<50) vs high disease activity (CRP>50).

Results:

Strong expression of 8-oxo-dG, 4HNE, Ang2 and Tie2 were demonstrated in the adventitial and intimal regions. 8-oxo-dG and 4HNE correlated with disease activity marker ESR (r=.568, p<0.017: r=.451, p<0.05 respectively). Expression of 8-oxodG significantly correlated with Tie2 (r=0.538, p<0.017) and that of 4HNE significantly correlated with Ang2 (r=0.0529, p<0.02).  A mixture of immature and mature blood vessels was demonstrated in all GCA patients, with a lower number of vessels expressing α-SMA in patients with high disease activity (41% ± 13.4) compared to low disease activity (66% ± 8.2) suggesting a more unstable vascular microenvironment is associated with high disease activity.  This was further supported when we demonstrated spontaneous release of pro-inflammatory mediators Ang2, MMP-2, MMP-9, IL-6 and IL-8 from ex vivo TA explants in culture. Furthermore conditioned media from TA explants significantly induced angiogenic tube formation (p<0.05). 

Conclusion:

This is the first study directly demonstrating that vessels in the inflamed temporal arteries from patients with GCA are unstable and are associated with incomplete EC/pericyte interactions, expression of Ang2 and oxidative damage markers.


Disclosure:

D. Molloy,
None;

J. McCormick,
None;

M. Connolly,
None;

M. Haroon,
None;

D. J. Veale,

Roche Pharmaceuticals,

5,

Pfizer Inc, MSD, Bayer,

5,

Pfizer Inc, MSD,

8;

C. Murphy,
None;

U. Fearon,
None;

E. S. Molloy,

Roche Pharmaceuticals,

2.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/blood-vessel-instability-and-oxidative-damage-in-giant-cell-arteritis/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology